COMPANY INVOLVEMENT

  • Deerland Enzymes & Probiotics
  • Renaissance Acquisition Holdings
  • Revision Skincare / Goodier Cosmetics
  • Santa Cruz Nutritionals

David J. Koo

Senior Advisor

Mr. Koo is a Senior Advisor and has been at the firm since its inception. His principal focus is assisting and advising the firm’s remaining Fund III and IV companies. Mr. Koo serves on the boards of directors of Revision Skincare/Goodier Cosmetics, Renaissance Pharmaceuticals, Santa Cruz Nutritionals and Deerland Probiotics & Enzymes. He previously served on the boards of directors of Aqua, Avalign, Bioniche Pharma, CorePharma, MedAssist, and Vesta. Additionally, he was very involved throughout the Sabex investment as well as the investments in Vanguard and Argon. Mr. Koo joined RoundTable as a Principal.

PROFESSIONAL EXPERIENCE

  • Senior Advisor, RoundTable, July 2019 – Present
  • Senior Transaction Partner, RoundTable, May 2006 – June 2019
  • Partner, RoundTable, February 2005 – April 2006
  • Principal, RoundTable, February 2001 – January 2005
  • Vice President, CSFB, U.S. Health Care Investment Banking Group, 1999 – 2001
  • Various Investment Banking Positions, CSFB, 1994 – 1999
  • Staff Accountant, KPMG Peat Marwick, Audit Department, 1993 – 1994


ACADEMIC BACKGROUND

  • Bachelor’s degree in Business Administration in Accountancy, University of Notre Dame, 1993
  • Certified Public Accountant (CPA), Illinois, 1993